Properties
Description
Cobimetinib racemate prevents the phosphorylation and activation of ERK leading to reduced cell proliferation and induced apoptosis in cancerous cells.
Molecular Formula
C21H21F3IN3O2
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Cobimetinib racemate can be used to investigate the inhibition of MEK1/2 for oncology research.